Ketamine + Magnesium for Chronic Cluster Headache (KETALGIA)

Recruiting

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(14 sites)

France

CH Annecy Genevois, Annecy

Polyclinique Jean Villar, Bruges

CHU de Clermont-Ferrand, Clermont-Ferrand

CHRU De Lille, Lille

Hospices civils de Lyon, Hôpital Pierre Wertheimer, Lyon

AP-HM Marseille, Marseille

Clinique Beau Soleil, Montpellier

CHU de Montpellier, Montpellier

CHU Nantes, Hopital Nord Laennec, Nantes

Hôpital Lariboisière, Paris

CHU Rouen, Rouen

Hopital de Hautepierre, Strasbourg

Hopital Pierre Paul Riquet, Toulouse

CHU Grenoble-Alpes, Voiron